Spot on mate.
Are there risks? Of course. Have there been some challenges? Yes. If you’re here for a quick buck, a low risk investment or consistent share price appreciation it’s probably not your thing.
But with the potential markets we are talking about, some very credible runs on the board in anti-microbial results and FDA QIDP grant as well as acne results that actually show some real promise, along with a highly experienced management team with a strong track record and plenty of cash in the bank, there is a very real (not imagined), but real opportunity for this to be massive.
Antimicrobial platform - BTX 1801 Phase 2a clinical study, page-40
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
33.0¢ |
Change
0.020(6.45%) |
Mkt cap ! $507.9M | |||
| Open | High | Low | Value | Volume |
| 31.0¢ | 33.5¢ | 30.5¢ | $2.397M | 7.503M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 414007 | 32.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.5¢ | 830330 | 9 |
View Market Depth
| Last trade - 15.45pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
33.0¢ |
Change
0.020 ( 6.73 %) |
||||
| Open | High | Low | Volume | ||
| 31.0¢ | 33.5¢ | 30.8¢ | 3931977 | ||
| Last updated 15.59pm 14/06/2024 ? | |||||
| BOT (ASX) Chart |